Sign in
4

Changes in Ownership

CORCEPT THERAPEUTICS INC Filed Acc 0000950170-25-032747

Chief Development Officer sold 20,000 shares at $59.07 ($1,181,400)

  • Chief Development Officer acquired 20,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Guyer William Chief Development Officer 2025-03-04 Option exercise 10b5-1 +20,000 $19.26 $385,200 25,487 D: show line 1 in the form
Guyer William Chief Development Officer 2025-03-04 Sale 10b5-1 −20,000 $59.07 $1,181,400 5,487 D: show line 2 in the form
Open-market sales · 20,000 sh · avg $59.07 · $1,181,400

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Guyer William Chief Development Officer 2025-02-28 Grant or award · Stock option (right to buy) 10b5-1 +140,000 140,000 D: show line 3 in the form
Guyer William Chief Development Officer 2025-03-04 Option exercise · Stock option (right to buy) 10b5-1 −20,000 30,000 D: show line 4 in the form
Loading xslF345X05/ownership.xml…